Patent · US Active

Abeta conformer selective anti-Abeta globulomer monoclonal antibodies

US9359430B2 · kind B2 · utility

4Cited by

189References

7Claims

0Family size

Assignees

Abb Vie Inc. · US
Abb Vie Deutschland Gmbh & Co. KG · DE

Inventors

Stefan Barghorn · Mannheim, DE
Heinz Hillen · Herbrechtingen, DE
Andreas Striebinger · Speyer, DE
Boris Labkovsky · Framingham, US
Ulrich Ebert · Mannheim, DE
Patrick Keller · Darmstadt, DE

Key dates

Filing date	Apr 15, 2013
Grant date	Jun 7, 2016
Priority date	—
Expiry date	Oct 23, 2033

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/2821
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The subject invention relates to monoclonal antibodies that may be used in the treatment and diagnosis of Alzheimer's Disease. In particular, the present invention relates to monoclonal antibodies referred to as 10F4 and 3C5 and to other monoclonal antibodies (e.g., murine, human or humanized) having similar properties thereto.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.